Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** The facility had a census of 56 residents. The sample included 15 residents with five reviewed for unnecessary medications. Based on observation, record review and interview, the facility failed to ensure the Consultant Pharmacist identified and reported to the Director of Nursing (DON), medical director, or physician about the lack of physician ordered blood sugar parameters for Resident (R) 32 and R3, and an inappropriate diagnosis for the use of an antipsychotic medication (medication used to treat significant mental health problems) for R54. This placed the residents at risk for adverse side effects related to abnormal blood sugars and antipsychotic medications.
Findings included:
- R32's Physician Order Sheet, dated 03/02/22, recorded diagnoses of dementia (progressive mental disorder characterized by failing memory and confusion) and diabetes mellitus (disease that impairs the body's ability to regulate blood sugar).
R32's Quarterly Minimum Data Set (MDS), dated 02/16/22, documented the resident had a Brief Interview for Mental Status (BIMS) score of 11 (moderate cognitive impairment). The MDS documented R32 had a diagnosis of diabetes and received insulin (medication used to regulate blood sugar levels) injections seven days a week.
The Diabetic Care Plan, dated 03/07/22, directed staff to check R32's blood sugars as ordered by the physician, monitor for signs and symptoms of hyperglycemia (more than normal amount of sugar in the blood) and hypoglycemia (less than normal amount of sugar in the blood), and notify the physician as needed.
The Physician's Order, dated 11/16/21, directed staff to administer Tresiba insulin (slow acting medication to regulate blood sugars) ten units to R32 at bedtime.
The Physician's Order, dated 11/17/21, directed staff to administer Novolog insulin (fast acting medication to regulate blood sugars) four units to R32 before meals.
The Physician's Order, dated 02/09/22, directed staff to check R32's blood sugar levels before meals and at bedtime (06:30 AM, 11:00 AM, 05:00 PM, 08:00 PM).
R32 was admitted to the facility on [DATE] and review of R32's medical record lacked documentation of physician ordered blood sugar parameters to direct staff to provide assessments, treatment and physician notification for abnormal blood sugars.
The Pharmacist Medication Reviews, dated 12/17/21, 01/17/22, 02/21/22, and 03/22/21, lacked documentation the pharmacist addressed R32 not having physician ordered blood sugar parameters.
On 03/31/22 at 08:04 AM, observation revealed R32 sat in her wheelchair at the dining table and ate independently with staff supervision.
On 04/04/22 at 03:40 PM, Licensed Nurse (LN) K stated staff checked R32's blood sugar and administered insulin as ordered by the physician. LN K stated R32 did not have physician ordered blood sugar parameters to direct staff to provide assessments, treatments and physician notification for abnormal blood sugars.
On 04/05/22 at 08:52 AM, Administrative Nurse D stated the consultant pharmacist had not addressed R32 not having physician ordered blood sugar parameters to direct cares and physician notification of abnormal blood sugars.
The facility's Medication Regimen Review policy, dated April 2019, directed the consultant pharmacist to address inadequate monitoring of medication effectiveness and adverse consequences.
The facility failed to ensure the Consultant Pharmacist identified and reported to the DON, medical director, or physician R32's lack of physician ordered blood sugar parameters, placing the resident at risk for adverse side effects related to abnormal blood sugars.
- The Physician Order Sheet, dated 01/06/22, recorded R54 had diagnoses of dementia with behaviors (persistent mental disorder marked by memory loss and impaired reasoning), depression (mood disorder that causes a persistent feeling of sadness and loss of interest), anxiety (mental health disorder characterized by worry and fear that interferes with daily life), and insomnia (difficulty sleeping).
The Quarterly Minimum Data Set (MDS), dated [DATE], recorded R54 had a Brief Interview for Mental Status (BIMS) score of two (severe cognitive impairment) and no behaviors. The MDS recorded R54 transferred and walked independently and received scheduled antipsychotic medication and antidepressant medication (medication used to treat moods and symptoms associated with depression) seven days a week.
The Medication Care Plan, dated 02/10/22, recorded R54 received Risperdal (antipsychotic medication) with a Black Box Warning (highest safety-related warning that medications can have assigned by the Food and Drug Administration) that recorded the medication was not approved for treatment of elderly patients with dementia, and side effects increased mortality. The Medication Care Plan directed staff to monitor R54 and report life-threatening side effects to the physician.
The Physician's Order, dated 11/29/21, directed staff to administer Risperdal (antipsychotic medication used to treat severe behavior problems) 0.5 milligrams (mg) at bedtime to R54 for dementia with behaviors.
R54's Medication Administration Record (MAR) directed staff to monitor and record the following behaviors each shift due to the resident's use of Risperdal: yelling, agitation, hallucinations, combative and refusing care. The MARs, dated October 2021, November 2021, December 2021, January 2022, February 2022 and March 2022, recorded R54 exhibited none of the listed behaviors.
The Pharmacist Medication Reviews, dated 12/17/21, 01/17/22, 02/21/22, and 03/22/22, lacked documentation the pharmacist addressed the inappropriate diagnosis of dementia with behaviors for R54's use of Risperdal.
On 04/04/22 at 07:58 AM, observation revealed R54 walked independently to the dining room, made food and drink choices, conversed with other residents and staff, and had no behaviors.
On 04/05/22 at 09:32 AM, Administrative Nurse D stated the Consultant Pharmacist had not addressed R54's inappropriate diagnosis for the use of Risperdal.
The facility's Medication Regimen Review policy, dated April 2019, directed the consultant pharmacist to address inadequate monitoring of medication effectiveness and adverse consequences.
The facility failed to ensure the Consultant Pharmacist identified and reported to the DON, medical director, or physician R54's inappropriate diagnosis for the use of an antipsychotic medication, placing the resident at risk for adverse side effects related to antipsychotic medications.
- R3's Physician Order Sheet (POS), dated 03/14/22, documented diagnoses including diabetes and diabetic peripheral angiopathy (blood vessel disease caused by high blood sugar levels.
The Quarterly Minimum Data Set (MDS), dated [DATE] , documented a Brief Interview for Mental Status (BIMS) score of 14, indicating intact cognition. The MDS documented R3 independent with eating, bed mobility, locomotion, required supervision for hygiene, toileting, transfers, and limited staff assistance for dressing. The MDS documented R3 received insulin (hormone that lowers the level of sugar in the blood)seven days of the lookback period.
The Diabetes Care Plan, dated 03/28/22, directed staff to obtain fasting (not having anything to eat or drink (except water) for at least eight hours) blood sugar levels as ordered by the doctor. Provide diabetes medication, blood sugar checks, labwork as ordered, notify the physician as requested of the results, and any adverse drug reactions.
The Physician Order, dated 10/15/21, directed staff to administer the following insulin:
Lispro (fast acting insulin), 10 units, three times daily.
Levemir (long acting insulin), 25 units at bedtime.
Review of R3's medical record revealed no physician orders for blood sugar checks or parameters to determine when to notify the physician of blood sugar levels.
R3's March 2022 Medication Administration Record revealed staff documentation of blood sugars ranging from 80 to 298 milligrams per deciliter (mg/dL) (normal is 70-110 mg/dL).
Pharmacist Reviews on 10/18/21, 11/28/21, 12/17/21, 01/06/22, 02/15/22, and 03/21/22 lacked notation for the lack of physician orders for blood sugar monitoring or parameters.
On 03/31/22 at 07:40 AM, observation revealed Certified Medication Aide (CMA) R administered medication to R3 who was in bed and took the medications whole with a few sips of water.
On 04/04/22 at 09:42 AM, Licensed Nurse (LN) G stated R3 did not have physician ordered blood sugar parameters for physician notification or holding of insulin. She stated R3's blood sugar levels were fairly steady and did not get too high or too low.
On 04/05/22 at 11:31 AM, Administrative Nurse D stated R3's blood sugar check order was included with the insulin order per facility standards. Administrative Nurse D stated if the physician requested accuchecks other than when insulin was ordered it would be in a specific order. Administrative Nurse D verified the lack of physician ordered blood sugar checks and parameters and verified the Consultant Pharmacist had not notified her of the lack of physician orders for blood sugar checks or parameters.
The facility's Obtaining a Fingerstick Glucose Level policy, dated October 2011, directed staff to verify there is a physician order for this procedure. The policy did not address parameters for determining when to notify the physician.
The facility's Medication Regimen Reviews policy, dated May 2019, documented the consultant pharmacist would perform a medication regimen review monthly to prevent, identify, report and resolve medication related problems, errors, and other irregularities. The consultant pharmacist would provide the director of nursing services and medical director with a copy of all medication regimen reports.
The facility failed to ensure the Consultant Pharmacist identified and reported to the Director of Nursing, medical director, or the physician, the lack of physician orders for blood sugar checks and parameters for physician notification of abnormal blood sugars. This deficient practice placed R3 at risk for lack of physician oversight.